Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy.
Shingo
S
Miyamoto
Hiroshi
H
Yagi
Fusanori
F
Yotsumoto
Tatsuhiko
T
Kawarabayashi
Eisuke
E
Mekada
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis*; D002986:Clinical Trials as Topic; D019008:Drug Resistance, Neoplasm / Q000502:physiology; D005260:Female; D015870:Gene Expression; D066257:Heparin-binding EGF-like Growth Factor; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism*; D009361:Neoplasm Invasiveness / Q000473:pathology; D009369:Neoplasms / Q000378:metabolism; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000378:metabolism*
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; C587883:HBEGF protein, human; D066257:Heparin-binding EGF-like Growth Factor; D036341:Intercellular Signaling Peptides and Proteins